Walid Abdelwahab | Research Associate Professor
university of montana

Walid Abdelwahab, Research Associate Professor, university of montana

Walid Abdelwahab is a Research Associate Professor at the University of Montana’s Center for Translational Medicine (CTM), where he leads the formulations group. With a Ph.D. in Chemistry and extensive experience in vaccine development and pharmaceutical research, he focuses on translating scientific discoveries into practical vaccine solutions. His work advances innovative vaccine designs, including the use of safe and effective adjuvants and novel delivery and targeting systems. He has expertise in nanotechnology-enabled drug delivery, analytical method development, pharmaceutical chemistry, vaccine R&D, and process development and technology transfer. Walid also contributes to immunotherapy research, leveraging immune-modulating technologies to develop treatments for cancer and autoimmune diseases. Passionate about global health, he collaborates with academic and industry partners to accelerate impactful vaccine innovation. As a speaker at World Vaccine Congress Washington 2026, he brings insight into the evolving vaccine delivery R&D landscape and strategic global partnerships. Driven by real-world impact, Walid is committed to advancing the next generation of vaccine technologies and improving public health worldwide.

Appearances:



Pre-Congress Workshops - Monday 30th March @ 14:00

VACCINE DELIVERY WORKSHOP

Advanced vaccine delivery methods: novel routes and technologies to optimize administration, efficacy, and accessibility.

2pm Chair’s Opening Remarks: Vaccine Delivery Landscape Overview

2:15pm -4:00pm Vaccine delivery presentations:

  • 2:15 Getting Vaccine Efficacy Right Begins With The Right Vaccine Adjuvant
  • 2:30 Needle-free Delivery Solutions Addressing Today’s Vaccine Hesitancy
  • 2:45 An Adaptable Formulation Platform Enabling Thermostability and Mucosal Delivery Across Biologic Modalities
  • 3:00 Where Skin Meets Science: Transforming Vaccination Through Dermal Delivery
  • 3:15 Application of Next Gen Tools Including Alternative Delivery Systems and AI To Vaccine and Adjuvant Development
  • 3:30 Progress Towards a Clinical Intranasal Klebsiella Vaccine
  • 3:45 Nucleic Acid Vaccines: Innovative Molecular Adjuvant Applications for the Elderly To Boost Durability And Efficacy Using Clostridioides difficile As a Model

4:00 Panel: Targeting Mucosal Surfaces in Respiratory Vaccine Development

  • Inducing mucosal IgA and T cell immunity
  • Formulation challenges for nasal and inhaled delivery
  • Applicability to flu, RSV, TB and COVID vaccines
  • Prospects for mucosal combo vaccines.

 

Session led by: Croda Inc
Session led by: PharmaJet
Session led by: Kindeva Drug Delivery
Session led by: Jurata
last published: 11/Mar/26 19:15 GMT

back to speakers